Optimizing Chromatographic Conditions for Protein Analysis with theACQUITY UPLC H-Class Bio System
Presented By
Across the pharmaceutical industry, there is growing emphasis on the development of biopharmaceuticals as the next wave of drugs contributing to human health. In this podcast series, we’ll be discussing how chromatographic analyses of biopharmaceuticals, particularly proteins, compare to the more familiar assays of small molecule drugs and the benefits that UPLC® Technology can offer. The types of assays will be described and the basis for choosing them is considered. We’ll also discuss recent developments in ways to improve an analytical method.
Biopharmaceutical proteins are often best analyzed using ion exchange chromatography. Optimization of these methods has become much more efficient with UPLC technology. In this episode, the steps and considerations required for developing an ion exchange method for protein analysis are discussed.
Add this Podcast feed to your media player
Leveraging an Enterprise Laboratory Informatics Platform to Maximize Scientific Data Advantage
September 9th 2024As data volumes and expectations for fast scientific discovery continue to increase, laboratory-based research organizations can no longer rely on a siloed approach to data management. To remain competitive, scientific organizations need to connect all their data, from discovery through manufacturing, in a unified informatics platform.
Modern HPLC Strategies: Improving Retention and Peak Shape for Basic Analytes
August 16th 2024In high-performance liquid chromatography (HPLC), it is common for bases and unreacted ionized silanols on silica-based columns to cause irreproducible retention, broad peaks, and peak tailing when working with basic analytes. David S. Bell, Lead Consultant at ASKkPrime LLC offers innovative HPLC strategies that can help mitigate such issues.